Haemonetics (HAE) Free Cash Flow (2009 - 2026)

Haemonetics' Free Cash Flow history runs 18 years deep, the most recent figure standing at $53.3 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 47.2% year-over-year to $53.3 million; the TTM figure through Mar 2026 stood at $260.4 million (up 82.83% YoY), while the FY2026 annual figure was $260.4 million, up 82.83% from the prior year.
• Free Cash Flow was $53.3 million for Q1 2026 at Haemonetics, down from $87.2 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $106.3 million in Q3 2025 to a low of -$33.1 million in Q2 2024.
• Historically, Free Cash Flow has averaged $38.7 million across 5 years, with a median of $37.6 million in 2022.
• Biggest YoY gain for Free Cash Flow was 526.93% in 2024; the steepest drop was 390.02% in 2024.
• A 5-year view of Free Cash Flow shows it stood at $47.6 million in 2022, then slumped by 131.93% to -$15.2 million in 2023, then soared by 331.92% to $35.2 million in 2024, then soared by 147.63% to $87.2 million in 2025, then slumped by 38.91% to $53.3 million in 2026.
• The last three Free Cash Flow figures came in at $53.3 million (Q1 2026), $87.2 million (Q4 2025), and $106.3 million (Q3 2025), per Business Quant data.